AbL Diagnostics SA
PAR:ABLD

Watchlist Manager

AbL Diagnostics SA

PAR:ABLD

Watchlist

Dividends

Discount Rate

Price: 2.84 EUR Market Closed

Market Cap: 45.8m EUR

Have any thoughts about
AbL Diagnostics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 2.84 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ABLD Alert

AbL Diagnostics SA

2.84

0.00 (0%)

52 Week Range	2.7 9.7
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

AbL Diagnostics SA

What unique competitive advantages
does AbL Diagnostics SA hold over its rivals?

What risks and challenges
does AbL Diagnostics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of AbL Diagnostics SA.

What unique competitive advantages
does AbL Diagnostics SA hold over its rivals?

What risks and challenges
does AbL Diagnostics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AbL Diagnostics SA.

Provide P/S
for AbL Diagnostics SA.

Provide P/E
for AbL Diagnostics SA.

Provide P/OCF
for AbL Diagnostics SA.

Provide P/FCFE
for AbL Diagnostics SA.

Provide P/B
for AbL Diagnostics SA.

Provide EV/S
for AbL Diagnostics SA.

Provide EV/GP
for AbL Diagnostics SA.

Provide EV/EBITDA
for AbL Diagnostics SA.

Provide EV/EBIT
for AbL Diagnostics SA.

Provide EV/OCF
for AbL Diagnostics SA.

Provide EV/FCFF
for AbL Diagnostics SA.

Provide EV/IC
for AbL Diagnostics SA.

Compare the intrinsic valuations
of AbL Diagnostics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AbL Diagnostics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of AbL Diagnostics SA compared to its peers.

Compare the P/E ratios
of AbL Diagnostics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing AbL Diagnostics SA with its peers.

Analyze the financial leverage
of AbL Diagnostics SA compared to its main competitors.

Show all profitability ratios
for AbL Diagnostics SA.

Provide ROE
for AbL Diagnostics SA.

Provide ROA
for AbL Diagnostics SA.

Provide ROIC
for AbL Diagnostics SA.

Provide ROCE
for AbL Diagnostics SA.

Provide Gross Margin
for AbL Diagnostics SA.

Provide Operating Margin
for AbL Diagnostics SA.

Provide Net Margin
for AbL Diagnostics SA.

Provide FCF Margin
for AbL Diagnostics SA.

Show all solvency ratios
for AbL Diagnostics SA.

Provide D/E Ratio
for AbL Diagnostics SA.

Provide D/A Ratio
for AbL Diagnostics SA.

Provide Interest Coverage Ratio
for AbL Diagnostics SA.

Provide Altman Z-Score Ratio
for AbL Diagnostics SA.

Provide Quick Ratio
for AbL Diagnostics SA.

Provide Current Ratio
for AbL Diagnostics SA.

Provide Cash Ratio
for AbL Diagnostics SA.

What is the historical Revenue growth
over the last 5 years for AbL Diagnostics SA?

What is the historical Net Income growth
over the last 5 years for AbL Diagnostics SA?

What is the current Free Cash Flow
of AbL Diagnostics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for AbL Diagnostics SA.

EV/EBITDA
Enterprise Value to EBITDA

-69.8

Current

-69.5

Median

8.8

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-69.8

Enterprise Value

45.8m EUR

EBITDA

-657.1k EUR

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
FR		AbL Diagnostics SA PAR:ABLD	45.8m EUR	-69.8
JP		Itochu Corp TSE:8001	11.2T JPY	11.8
JP		Mitsubishi Corp TSE:8058	11T JPY	11.6
JP		Mitsui & Co Ltd TSE:8031	9.6T JPY	13.3
US		W W Grainger Inc NYSE:GWW	54.7B USD	19.9
US	W	WW Grainger Inc XMUN:GWW	49.3B EUR	19.6
US		United Rentals Inc NYSE:URI	52.4B USD	9.3
IN	A	A-1 Acid Ltd BSE:542012	4T INR	376 638.7
US		Fastenal Co NASDAQ:FAST	44.7B USD	26.3
UK	F	Ferguson PLC NYSE:FERG	40.6B USD	14.7
IN		Adani Enterprises Ltd NSE:ADANIENT	3.3T INR	29.9

				EBITDA Growth
FR		AbL Diagnostics SA PAR:ABLD	Average EV/EBITDA: 37 679.5 Negative Multiple: -69.8	N/A
JP		Itochu Corp TSE:8001	11.8	15%
JP		Mitsubishi Corp TSE:8058	11.6	1%
JP		Mitsui & Co Ltd TSE:8031	13.3	17%
US		W W Grainger Inc NYSE:GWW	19.9	21%
US	W	WW Grainger Inc XMUN:GWW	19.6	21%
US		United Rentals Inc NYSE:URI	9.3	18%
IN	A	A-1 Acid Ltd BSE:542012	376 638.7	N/A
US		Fastenal Co NASDAQ:FAST	26.3	19%
UK	F	Ferguson PLC NYSE:FERG	14.7	25%
IN		Adani Enterprises Ltd NSE:ADANIENT	29.9	115%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

N/A

2-Years Forward

EV/EBITDA

N/A

3-Years Forward

EV/EBITDA

N/A

AbL Diagnostics SA
PAR:ABLD

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

AbL Diagnostics SA PAR:ABLD

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

AbL Diagnostics SA
PAR:ABLD

EV/EBITDA
Enterprise Value to EBITDA